Methylation of the FGFR2 gene is associated with high birth weight centile in humans

Epigenomics

Volumn 6, Issue 5, 2014, Pages 477-491

  Haworth, Kim E ^a   Farrell, William E ^a   Emes, Richard D ^b,c   Ismail, Khaled M K ^d   Carroll, William D ^e   Hubball, Emma ^f   Rooney, Angela ^f   Yates, Alexandra M ^a   Mein, Charles ^g   Fryer, Anthony A ^a  

^a KEELE UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e DERBYSHIRE CHILDREN S HOSPITAL   (United Kingdom)

^f UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^g QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

birth weight centile; cord blood; DNA methylation; epigenetic genetic interactions; FGFR2

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 2;

ARTICLE; COHORT ANALYSIS; CPG ISLAND; DNA METHYLATION; DNA POLYMORPHISM; FEMALE; FGFR2 GENE; GENE; GENE INTERACTION; GENETIC VARIABILITY; GENOTYPE; HIGH BIRTH WEIGHT; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; POLYMERASE CHAIN REACTION; PYROSEQUENCING; UMBILICAL CORD BLOOD; ADULT; BIRTH WEIGHT; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETICS; REPRODUCIBILITY; YOUNG ADULT;

ADULT; BIRTH WEIGHT; CPG ISLANDS; DNA METHYLATION; FEMALE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; INFANT, NEWBORN; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 84913614721     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.14.40     Document Type: Article

References (44)

1. Waterland RA. Is epigenetics an important link between early life events and adult disease? Horm. Res. 71(Suppl 1), 13-16 (2009).
2. Brenseke B, Prater MR, Bahamonde J, Gutierrez JC. Current thoughts on maternal nutrition and fetal programming of the metabolic syndrome. J. Pregnancy 368461 (2013).
3. Brumbaugh DE, Friedman JE. Developmental origins of nonalcoholic fatty liver disease. Pediatr. Res. 75(1-2), 140-147 (2014).
4. Tarry-Adkins JL, Ozanne SE. The impact of early nutrition on the ageing trajectory. Proc. Nutr. Soc. 73(2), 289-301 (2014).
5. Waterland RA, Michels KB. Epigenetic epidemiology of the developmental origins hypothesis. Annu. Rev. Nutr. 27, 363-388 (2007).
6. Plagemann A, Harder T, Schellong K, Schulz S, Stupin JH. Early postnatal life as a critical time window for determination of long-term metabolic health. Best Pract. Res. Clin. Endocrinol. Metab. 26(5), 641-653 (2012).
7. Desai M, Beall M, Ross MG. Developmental origins of obesity: programmed adipogenesis. Curr. Diab. Rep. 13(1), 27-33 (2013).
8. Nafee TM, Farrell WE, Carroll W, Fryer AA, Ismail KMK. Epigenetic control of fetal gene expression. BJOG 115(2), 158-168 (2008).
9. Barnes SK, Ozanne SE. Pathways linking the early environment to long-term health and lifespan. Prog. Biophys. Mol. Biol. 106(1), 323-336 (2011).
10. Fryer AA, Nafee TM, Ismail KM, Carroll WD, Emes RD, Farrell WE. LINE-1 DNA methylation is inversely correlated with cord plasma homocysteine in man: a preliminary study Epigenetics 4(6), 394-398 (2009).
11. Fryer AA, Emes RD, Ismail KM et al. Quantitative, high-resolution epigenetic profling of CpG loci identifes associations with cord blood plasma homocysteine and birth weight in humans. Epigenetics 6(1), 86-94 (2011).
12. Michels KB, Harris HR, Barault L. Birthweight, maternal weight trajectories and global DNA methylation of LINE-1 repetitive elements. PLoS One 6, e25254 (2011).
13. Schroeder JW, Conneely KN, Cubells JC et al. Neonatal DNA methylation patterns associate with gestational age. Epigenetics 6(12), 1498-1504 (2011).
14. Turan N, Ghalwash MF, Katari S, Coutifaris C, Obradovic Z, Sapienza C. DNA methylation differences at growth related genes correlate with birth weight: a molecular signature linked to developmental origins of adult disease? BMC. Med. Genomics 5, 10 (2012).
15. Haworth KE, Farrell WE, Emes RD et al. Combined infuence of gene-specifc cord blood methylation and maternal smoking habit on birth weight. Epigenomics 5(1), 37-49 (2013).
16. Boks MP, Derks EM, Weisenberger DJ et al. The relationship of DNA methylation with age, gender and genotype in twins and healthy controls. PLoS One 4, e6767 (2009).
17. Fraser HB, Lam LL, Neumann SM, Kobor MS. Population-specifcity of human DNA methylation. Genome Biol. 13(2), R8 (2012).
18. Liu Y, Aryee MJ, Padyukov L et al. Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis. Nat. Biotechnol. 31(2), 142-147 (2013).
19. Emes RD, Clifford H, Haworth KE et al. Antiepileptic drugs and the fetal epigenome. Epilepsia 54(1), e16-e19 (2013).
20. Bibikova M, Barnes B, Tsan C et al. High density DNA methylation array with single CpG site resolution. Genomics 98(4), 288-295 (2011).
21. Sandoval J, Heyn H, Moran S et al. Validation of a DNA methylation microarray for 450, 000 CpG sites in the human genome. Epigenetics 6(6), 692-702 (2011).
22. Dedeurwaerder S, Defrance M, Calonne E, Denis H, Sotiriou C, Fuks F. Evaluation of the Infnium Methylation 450K technology. Epigenomics 3 (6), 771-784 (2011).
23. Wessely F, Emes RD. Identifcation of DNA methylation biomarkers from Infnium arrays. Front Genet. 3, 161 (2012).
24. Glossop JR, Nixon NB, Emes RD et al. Epigenome-wide profling identifes signifcant differences in DNA methylation between matched-pairs of T-and B-lymphocytes from healthy individuals. Epigenetics 8(11), 1188-1197 (2013).
25. Duong C, Emes R, Wessely F, Yacqub-Usman K, Clayton R, Farrell W Quantitative, genome-wide analysis of the DNA methylome in sporadic pituitary adenomas. Endocr. Relat. Cancer 19(6), 805-816 (2012).
26. Zhang D, Cheng L, Badner JA et al. Genetic control of individual differences in gene-specifc methylation in human brain. Am. J. Hum. Genet. 86(3), 411-419 (2010).
27. Bell JT, Tsai PC, Yang TP et al. Epigenome-wide scans identify differentially methylated regions for age and age-related phenotypes in a healthy ageing population. PLoS Genet. 8(4), e1002629 (2012).
28. Zhi D, Aslibekyan S, Irvin MR et al. SNPs located at CpG sites modulate genome-epigenome interaction. Epigenetics 8(8), 802-806 (2013).
29. Drong AW, Nicholson G, Hedman AK et al. The presence of methylation quantitative trait loci indicates a direct genetic infuence on the level of DNA methylation in adipose tissue. PLoS One 8(2), e55923 (2013).
30. Chen Y, Lemire M, Choufani S et al. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infnium HumanMethylation450 microarray. Epigenetics 8(2), 203-209 (2013).
31. Soto-Ramírez N, Arshad SH, Holloway J W, Zhang H, Schauberger E, Ewart S et al. The interaction of genetic variants and DNA methylation of the interleukin-4 receptor gene increase the risk of asthma at age 18 years. Clin. Epigenetics 5(1), 1 (2013).
32. Scherf DB, Sarkisyan N, Jacobsson H et al. Epigenetic screen identifes genotype-specifc promoter DNA methylation and oncogenic potential of CHRNB4. Oncogene 32(28), 3329-3338 (2013).
33. Tamimi RM, Lagiou P, Czene K et al. Birth weight, breast cancer susceptibility loci, and breast cancer risk. Cancer Causes Control. 21(5), 689-696 (2010).
34. Zhou L, Yao F, Luan H et al. Three novel functional polymorphisms in the promoter of FGFR2 gene and breast cancer risk: a HuGE review and meta-analysis. Breast Cancer Res. Treat. 136(3), 885-897 (2012).
35. Park SK, Kang D, McGlynn KA et al. Intrauterine environments and breast cancer risk: meta-analysis and systematic review. Breast Cancer Res. 10(1), R8 (2008).
36. Xu X, Dailey AB, Peoples-Sheps M, Talbott EO, Li N, Roth J. Birth weight as a risk factor for breast cancer: a meta-analysis of 18 epidemiological studies. J. Womens Health (Larchmt). 18 (8), 1169-1178 (2009).
37. Berstein LM. High baby birth weight and risk of hormone-associated cancer in mothers: the cancer-cardiovascular disease dichotomy and its possible causes. Womens Health (London, England). 9(4), 361-371 (2013).
38. Hale C, Chen MM, Stanislaus S et al. Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance. Endocrinology 153(1), 69-80 (2012).
39. Woo YC, Xu A, Wang Y, Lam KS. Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives. Clin. Endocrinol. (Oxford)78(4), 489-496 (2013).
40. Fletcher JA, Meers GM, Laughlin MH, Ibdah JA, Thyfault JP, Rector RS. Modulating fbroblast growth factor 21 in hyperphagic OLETF rats with daily exercise and caloric restriction. Appl. Physiol. Nutr. Metab. 37(6), 1054-1062 (2012).
41. Murphy SK, Yang H, Moylan CA et al. Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease. Gastroenterology 145(5), 1076-1087 (2013).
42. Arman E, Haffner-Krausz R, Gorivodsky M, Lonai P. Fgfr2 is required for limb outgrowth and lung-branching morphogenesis. Proc. Natl Acad. Sci. 96 (21), 11895-11899 (1999).
43. Merrill AE, Sarukhanov A, Krejci P et al. Bent bone dysplasia-FGFR2 type, a distinct skeletal disorder, has defcient canonical FGF signaling. Am. J. Hum. Genet. 90(3), 550-557 (2012).
44. Liver and myocardial iron overload: online supplement. http://oernst.f5lvg.free.fr/liver/iron.html